greeksoup/ stock research
Stock research / United States / Funds / Blue Water Life Science Advisors, LP

Blue Water Life Science Advisors, LP

CIK 1789778 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

Blue Water Life Science Advisors, LP reported 9 US-listed holdings worth $158.8 million in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Caredx Inc. (21.4%), 10X Genomics Inc. (15.5%) and Personalis Inc. (14.1%). Against the quarter before, it opened 0 positions, added to 3, trimmed 4 and sold out of 1.

Reported holdings$158.8M+27.3% on Q1 2026
Positions9-1 on Q1 2026
The largest ten100.0%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
Added toHeldTrimmed
CDNA21.4%TXG15.5%PSNL14.1%ADPT13.6%GH10.8%QTRX9.5%NTRA5.9%BLLN5.3%TEM3.8%

The 9 largest of its 9 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $113.7 million in 8 positions$114MQ3 24Q4 2024: $112.9 million in 9 positions$113MQ4 24Q1 2025: $100.9 million in 7 positions$101MQ1 25Q2 2025: $126.3 million in 8 positions$126MQ2 25Q3 2025: $109.6 million in 7 positions$110MQ3 25Q4 2025: $159.3 million in 9 positions$159MQ4 25Q1 2026: $124.7 million in 10 positions$125MQ1 26Q2 2026: $158.8 million in 9 positions$159MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +155.5% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
100150200250Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +155.5%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Added 3Held 2Trimmed 4Sold out 1
Added: 3Held: 2Trimmed: 4Sold out: 1

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Added to 3

  1. Caredx Inc. CDNA+255,000 shares · +27%
  2. Billiontoone Inc. BLLN+50,000 shares · +250%
  3. Quanterix Corp. QTRX+1.3 million shares · +62%

Trimmed 4

  1. Guardant Health Inc. GH-127,500 shares · -53%
  2. 10X Genomics Inc. TXG-448,000 shares · -41%
  3. Tempus Ai Inc. TEM-51,000 shares · -33%
  4. Natera Inc Com NTRA-10,300 shares · -23%

Sold out of 1

  1. Twist Bioscience Corp. TWST$13.1 million last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Caredx Inc. CDNA1.2M$33.9 million21.36%+255.0K
10X Genomics Inc. TXG642.0K$24.6 million15.50%-448.0K
Personalis Inc. PSNL1.7M$22.5 million14.15%no change
Adaptive Biotechnologies Corporation ADPT1.0M$21.7 million13.65%no change
Guardant Health Inc. GH114.7K$17.2 million10.84%-127.5K
Quanterix Corp. QTRX3.5M$15.0 million9.45%+1.3M
Natera Inc Com NTRA34.5K$9.4 million5.90%-10.3K
Billiontoone Inc. BLLN70.0K$8.4 million5.29%+50.0K
Tempus Ai Inc. TEM105.4K$6.1 million3.85%-51.0K
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 1 it sold out of are in the box above.